Axis 2
Studiedness
- Evidence amount
- 1.00
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 50
- Records after title/year deduplication
- 50
entity · release 2026-09-20
Lactobacillus acidophilus LA-5
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Printed CFU per serving
- 250,000,000 – 1,250,000,000; median 840,000,000. Measured on the 3 of 9 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
- Forms
- Capsule: 9 · counted across the 9 of 9 published products whose label states a form
- Brands carrying it
- bayer-one-a-day (1) · renew-life (2) · solgar (2) · trubiotics (1) · vitaceutical-labs (2) · the five largest of 6 brands with a published product
- Published product pages
- 9
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| Solgar Advanced Acidophilus Plus | 250,000,000 | not printed | not observed | Capsule | 100.00 |
| TruBiotics TruBiotics | not printed | not printed | not observed | Capsule | 88.75 |
| VitaCeutical Labs Dual Action Acidophilus & Bifidus | not printed | not printed | not observed | Capsule | 88.75 |
| Solgar Advanced Multi-Billion Dophilus | 1,250,000,000 | not printed | not observed | Capsule | 84.25 |
| Bayer One A Day TruBiotics | not printed | not printed | not observed | Capsule | 77.50 |
| VitaCeutical Labs Probiotic Quattro | 840,000,000 | not printed | not observed | Capsule | 77.50 |
| SuperSmart Candalb | not printed | not printed | not observed | Capsule | 61.75 |
| Renew Life Probiotics Occasional Constipation Support 20 Billion CFU | not printed | not printed | not observed | Capsule | 56.53 |
| Renew Life Daily Balance 20 Billion CFU | not printed | not printed | not observed | Capsule | 51.00 |
Reformulations
Label changes involving this organism
2 change(s) to this organism's own row, observed on 1 product(s). A change is counted only between two snapshots whose ingredient rows were both parsed; a first observation is not a change.
- Solgar Advanced Acidophilus Plus: 44161 → 241240, potency basis unstated → through_expiry
- Solgar Advanced Acidophilus Plus: 44163 → 241240, potency basis unstated → through_expiry
Containing labels20
Evidence amount1.00
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
50 records (retracted records excluded; 1 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2026 · Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
- 2026 · The Effect of Lactobacillus Acidophilus (La5) on the Incidence of Urinary Tract Infection in the Puerperium: A Randomized Placebo-Controlled Trial.
- 2024 · Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical Trial.
- 2024 · A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
- 2023 · Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial.
- 2022 · A Four-Probiotic Regime to Reduce Surgical Site Infections in Multi-Trauma Patients.
- 2022 · A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial.
- 2021 · A comparative evaluation of probiotic formulations in prevention of dental caries: A clinical study.
- 2021 · Immune status, well-being and gut microbiota in military supplemented with synbiotic ice cream and submitted to field training: a randomised clinical trial.
- 2021 · Daily consumption effects of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 on oxidative stress in metabolic syndrome patients.
ClinicalTrials.gov
17 interventional studies. ClinicalTrials.gov query
This species has 45 tracked designations; this one appears on 20 labels (median 4).
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 20 of 20 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Solgar | Advanced Acidophilus Plus | 241240 | 100.00 | true | 250,000,000 CFU | through expiry | 4 |
| Solgar | Advanced Acidophilus Plus | 264106 | 100.00 | true | 250,000,000 CFU | through expiry | 4 |
| VitaCeutical Labs | Dual Action Acidophilus & Bifidus | 6396 | 88.75 | false | not printed for this organism | through expiry | 1 |
| Bayer One A Day | TruBiotics with Immune Support Advantage | 178453 | 88.75 | true | not printed for this organism | through expiry | 1 |
| TruBiotics | TruBiotics | 316470 | 88.75 | true | not printed for this organism | through expiry | 1 |
| Solgar | Advanced Multi-Billion Dophilus | 264116 | 84.25 | true | 1,250,000,000 CFU | through expiry | 1 |
| VitaCeutical Labs | Probiotic Quattro | 6397 | 77.50 | false | 840,000,000 CFU | at manufacture | 1 |
| Bayer One A Day | TruBiotics | 178450 | 77.50 | true | not printed for this organism | not stated | 1 |
| SuperSmart | Candalb | 285342 | 61.75 | true | not printed for this organism | not stated | 2 |
| SuperSmart | Candalb | 339804 | 61.75 | true | not printed for this organism | not stated | 2 |
| Renew Life | Probiotics Occasional Constipation Support 20 Billion CFU | 306948 | 56.53 | true | not printed for this organism | through expiry | 1 |
| Renew Life | Daily Balance 20 Billion CFU | 306946 | 51.00 | true | not printed for this organism | through expiry | 1 |
| Solgar | Advanced Acidophilus Plus | 44161 | Not available in this release. | true | undefined: light snapshot | not stated | 4 |
| Solgar | Advanced Acidophilus Plus | 44163 | Not available in this release. | true | undefined: light snapshot | not stated | 4 |
| Solgar | Advanced 40+ Acidophilus | 44247 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Solgar | Advanced Multi-Billion Dophilus | 79324 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Solgar | Advanced 40+ Acidophilus | 80971 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Solgar | Advanced Acidophilus | 81368 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Solgar | Multi-Acidophilus Powder | 214664 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Solgar | Advanced Acidophilus | 217189 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Lactobacillus acidophilus LA-5. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/lactobacillus-acidophilus-la-5/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Lactobacillus acidophilus LA-5 appears on 20 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 6 brands; tied with 3 designations by distinct label count.
20 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324374 of 20 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Lactobacillus acidophilus LA-5 (20.0%); 8 light records have quantities unavailable.
4 / 20 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f73243750 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 50 records (retracted records excluded; 1 retracted records match the query separately).
50 / 50 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f73243717 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
17 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 16 SKUs containing Lactobacillus acidophilus LA-5 have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.
0 / 16 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437